CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in PRLD — Prelude Therapeutics Inc
CIK 884546
SAN FRANCISCO, CA
Position in PRLD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$360,425
+$295,022 QoQ
Shares Held
67,622
-16.4% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 75 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. PRLD ranks #271 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in PRLD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,425 | 67,622 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $65,403 | 80,845 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $87,590 | 114,050 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $149,430 | 117,200 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $275,825 | 133,249 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $487,805 | 128,033 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $603,733 | 127,370 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $532,469 | 124,700 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $380,165 | 123,031 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $386,068 | 85,793 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $358,250 | 62,851 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $384,874 | 63,721 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $357,283 | 54,052 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $329,904 | 63,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $523,917 | 75,930 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,059,955 | 85,137 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,624,531 | 83,985 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,079,196 | 72,623 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,235,364 | 74,668 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,906,040 | 68,568 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||